Skip to main content
AI/ML Innovations Inc. logo

AI/ML Innovations Inc. — Investor Relations & Filings

Ticker · AIML ISIN · CA00143Y1034 LEI · 5493004TJHMBXORVTD12 CSE Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 291 across all filing types
Latest filing 2025-12-23 Management Reports
Country CA Canada
Listing CSE AIML

About AI/ML Innovations Inc.

https://aiml-innovations.com/

AI/ML Innovations Inc. is a digital healthcare technology company specializing in the application of Artificial Intelligence (AI) and Machine Learning (ML) neural networks to revolutionize non-invasive medicine and biometric intelligence. The company develops proprietary platforms that leverage advanced signal processing and deep learning to convert complex biometric data into actionable clinical insights, supporting proactive and personalized care. Its flagship technology, MaxYield, is a cutting-edge Signal Processing Neural Network designed to extract high-fidelity signals from noisy recordings, initially focused on enhancing the clarity and accuracy of ECG data by delivering clean, "Neuralized" waveforms and precise PQRST data walls. Through its subsidiaries, the company provides AI-powered solutions like CardioYield™ for Holter analysis, aiming to integrate seamlessly with existing clinical and wellness workflows.

Recent filings

Filing Released Lang Actions
Interim MD&A - English.pdf
Management Reports Classification · 1% confidence The document is explicitly titled 'Management's Discussion & Analysis' (MD&A) for AI/ML Innovations Inc. It covers the financial condition, results of operations, and business outlook for the three and six months ended October 31, 2025. It includes detailed financial tables, analysis of quarterly performance, and management's commentary on strategic initiatives, which aligns perfectly with the definition of an MDA filing.
2025-12-23 English
News release - English.pdf
Regulatory Filings Classification · 1% confidence The document is a press release announcing a new commercial partnership and term sheet agreement between AI/ML Innovations Inc. and Culminate H Labs. It details the integration of technology platforms (MaxYield and Insight360) into a partner's ecosystem. As this is a corporate announcement regarding business operations and partnerships that does not fit into specific financial reporting categories like 10-K or IR, and is not a report publication announcement, it falls under the general regulatory filing/announcement category.
2025-12-09 English
News release - English.pdf
Regulatory Filings Classification · 1% confidence The document is a press release issued by AI/ML Innovations Inc. announcing a new pilot project collaboration with The Hospital for Sick Children (SickKids). It describes business operations, technology development, and strategic partnerships. It does not fit into specific financial reporting categories like 10-K, IR, or ER, nor is it a report publication announcement (RPA) as it is the primary source of the news itself. Therefore, it falls under the general regulatory/corporate announcement category.
2025-11-24 English
News release - English.pdf
Regulatory Filings Classification · 1% confidence The document is a corporate press release announcing a business collaboration (subsidiary engaging Lonacas for regulatory submission in Jamaica) and a stock option grant. It does not present financial results (not an ER or IR), no annual or interim report, no call transcript, no M&A or financing deal, no AGM materials, no dividend notice, and no detailed governance or compensation proxy statement. It is a general corporate announcement. Therefore it falls into the fallback category “Regulatory Filings” (RNS).
2025-11-04 English
News release - English.pdf
Regulatory Filings Classification · 1% confidence The document is a corporate press release announcing the launch of a pilot program for a health-tech product in Jamaica. It contains no financial results, no funding or financing details, no regulatory report, no meeting materials, no vote results, no share transactions, and no interim or annual financial statements. It is not an investor presentation deck, nor is it announcing the publication of a formal report. Therefore, it does not match any specific category such as Earnings Release, Interim Report, M&A Activity, or Disclosure of Share Transactions. It is a general corporate announcement. The appropriate fallback classification in our taxonomy for miscellaneous regulatory announcements and press releases that don’t fit other categories is "Regulatory Filings" (RNS).
2025-10-16 English
Report of exempt distribution (45-106F1).pdf
Regulatory Filings Classification · 1% confidence The document is a filled-out Canadian Form 45-106F1 "Report of Exempt Distribution," which is a mandatory regulatory filing disclosing details of a securities distribution under exemptions. It is not an annual or interim report, earnings release, management discussion, proxy statement, nor an investor presentation. It does not fall under specific categories such as director dealings or M&A activity. Therefore, it is best classified under the fallback category for general regulatory filings (RNS).
2025-09-27 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.